Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix

Br J Cancer. 2010 Jan 5;102(1):23-6. doi: 10.1038/sj.bjc.6605415. Epub 2009 Nov 17.

Abstract

Background: There is a need for simple imaging parameters capable of predicting therapeutic outcome.

Methods: This retrospective study analysed 50 patients with locally advanced carcinoma of the cervix who underwent dynamic contrast-enhanced MRI before receiving potentially curative radiotherapy. The proportion of enhancing pixels (E(F)) in the whole-tumour volume post-contrast agent injection was calculated and assessed in relation to disease-free survival (DFS).

Results: Tumours with high E(F) had a significantly poorer probability of DFS than those with low E(F) (P=0.011).

Interpretation: E(F) is a simple imaging biomarker that should be studied further in a multi-centre setting.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / blood supply
  • Adenocarcinoma / radiotherapy
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Adenosquamous / blood supply
  • Carcinoma, Adenosquamous / radiotherapy
  • Carcinoma, Squamous Cell / blood supply*
  • Carcinoma, Squamous Cell / mortality
  • Carcinoma, Squamous Cell / radiotherapy
  • Contrast Media*
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Gadolinium DTPA*
  • Humans
  • Image Processing, Computer-Assisted / methods*
  • Image Processing, Computer-Assisted / statistics & numerical data
  • Kaplan-Meier Estimate
  • Magnetic Resonance Imaging / methods*
  • Middle Aged
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local / epidemiology
  • Neoplasm, Residual
  • Neovascularization, Pathologic / pathology*
  • Retrospective Studies
  • Uterine Cervical Neoplasms / blood supply*
  • Uterine Cervical Neoplasms / mortality
  • Uterine Cervical Neoplasms / radiotherapy

Substances

  • Contrast Media
  • Gadolinium DTPA